Back to search
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
Data up to Jan 2025
Published2001
Citations77
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...